Black Rock Inc. Maxcyte, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,142,364 shares of MXCT stock, worth $33.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,142,364

Previous 7,229,573 12.63%

Holding current value

$33.1 Million

Previous $30.3 Million 5.37%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.63 - $5.0 $3.31 Million - $4.56 Million	912,791 Added 12.63%	8,142,364 $31.9 Million
Q1 2024 May 10, 2024	SELL	$3.94 - $5.38 $440,543 - $601,553	-111,813 Reduced 1.52%	7,229,573 $30.3 Million
Q4 2023 Feb 13, 2024	BUY	$2.6 - $5.24 $1.18 Million - $2.38 Million	453,390 Added 6.58%	7,341,386 $34.5 Million
Q3 2023 Nov 13, 2023	SELL	$3.02 - $5.1 $96,905 - $163,648	-32,088 Reduced 0.46%	6,887,996 $21.5 Million
Q2 2023 Aug 11, 2023	SELL	$3.69 - $5.35 $371,129 - $538,086	-100,577 Reduced 1.43%	6,920,084 $31.8 Million
Q1 2023 May 12, 2023	BUY	$4.03 - $5.89 $828,483 - $1.21 Million	205,579 Added 3.02%	7,020,661 $34.8 Million
Q4 2022 Feb 13, 2023	BUY	$4.92 - $7.4 $1.81 Million - $2.72 Million	367,139 Added 5.69%	6,815,082 $37.2 Million
Q3 2022 Nov 14, 2022	BUY	$4.52 - $6.51 $3.55 Million - $5.11 Million	784,524 Added 13.85%	6,447,943 $41.9 Million
Q2 2022 Aug 12, 2022	BUY	$3.59 - $6.81 $788,299 - $1.5 Million	219,582 Added 4.03%	5,663,419 $26.8 Million
Q1 2022 May 12, 2022	BUY	$5.26 - $10.84 $1.21 Million - $2.49 Million	229,373 Added 4.4%	5,443,837 $38.1 Million
Q4 2021 Feb 10, 2022	BUY	$8.87 - $12.94 $40.2 Million - $58.7 Million	4,535,552 Added 668.06%	5,214,464 $53.1 Million
Q3 2021 Nov 09, 2021	BUY	$12.21 - $17.2 $8.29 Million - $11.7 Million	678,912 New	678,912 $8.29 Million

Others Institutions Holding MXCT

# of Institutions

124

Shares Held

65.6M

Call Options Held

Put Options Held

View Full List

About MAXCYTE, INC.

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $414M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

More about MXCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account